Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Sees Significant

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 238,700 shares, a growth of 50.8% from the March 31st total of 158,300 shares. Based on an average daily volume of 215,100 shares, the […]

Related Keywords

, Vanguard Group Inc , Corvus Pharmaceuticals , Nasdaq , Corvus Pharmaceuticals Inc , Discovery Capital Management , Renaissance Technologies , News Ratings For Corvus Pharmaceuticals Daily , Corvus Pharmaceuticals Price Performance , Corvus Pharmaceuticals Company Profile , Get Rating , Capital Management , Two Sigma Advisers , Sigma Advisers , Adenosine Production Inhibitor , Corvus Pharmaceuticals Daily , Nasdaq Crvs , Ccrvs , Medical , Stocks , Options , Put , Call ,